Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2021, Vol. 35 ›› Issue (5): 1-10.doi: 10.6040/j.issn.1673-3770.0.2021.010

    Next Articles

Intratympanic injections and systemic glucocorticoid treatment for sudden hearing loss: a systematic review and Meta-analysis

ZHONG Liping1,2, GUAN Xilong1,2, WANG Jingjing1,2, TANG Yong1,3   

  1. 1. Clinical Medical College of Changchun University of Chinese Medicine, Changchun 130117, Jilin, China;
    2. Department of Otorhinolaryngology, Jilin Province People's Hospital, Changchun 130021, Jilin, China;
    3. Department of Otorhinolaryngology, The Third Affiliated Hospital of Changchun University of Chinese Medicine, Changchun 130117, Jilin, China
  • Published:2021-09-29

PDF (PC)

357

Abstract: Objective To assess the efficacy, healing rate, and safety of intratympanic injections and systemic glucocorticoids in the initial treatment of sudden hearing loss. Methods The Web of Science, PubMed, Embase, Cochrane Library, CNKI, Wanfang and VIP databases were searched, and all RCTs involving intratympanic injection and systemic glucocorticoids in the treatment of sudden hearing loss before July 2020 were extracted. The literature was analyzed according to their inclusion and exclusion criteria, and their quality was evaluated using the Cochrane Handbook 5.1. Data were extracted and analyzed using RevMan 5.3 Meta-analysis software. Results Nine randomized controlled trials were identified, comprising three papers in Chinese and six in English.A total of 757 cases were included, of which 396 had been treated with intratympanic injections and 361 with systemic glucocorticoids. The Meta-analysis revealed no differences in the total effectiveness rate, healing rate, and mean pure tone average(PTA)gain between intratympanic injections and systemic glucocorticoid treatment(Relative Risk(RR)=1.05, 95% Confidence Interval(CI)=0.65-1.23; RR=1.01, 95%CI=0.79-1.30; and RR=1.18, 95%CI=-0.60-2.96, respectively). The subgroup analysis revealed no significant difference in PTA gain between the severe group and the moderate-to-severe group, and internal research revealed that intratympanic injections were more efficient than systemic glucocorticoids, while foreign research reported no significant difference between them. The major complications of intratympanic injection were transient vertigo and tinnitus, while the incidence of local complications was lower than that observed with systemic steroid treatment, which included high blood glucose, high blood pressure, and insomnia. Conclusion This study revealed no difference in the effectiveness and cure rates of sudden sensorineural hearing loss between intratympanic injections and systematic steroid use. Fewer side effects are associated with postauricular injections than systematic steroid therapy.

Key words: Sudden hearing loss, Glucocorticoids, Intratympanic injection, Efficacy, Meta-analysis

CLC Number: 

  • R764.43+7
[1] 中华耳鼻咽喉头颈外科杂志编辑委员会, 中华医学会耳鼻咽喉头颈外科学分会. 突发性聋的诊断和治疗指南(2005年, 济南)[J]. 中华耳鼻咽喉头颈外科杂志, 2006, 41(8): 569. doi:10.3760/j.issn: 1673-0860.2006.08.003. Chinese Otorhinolaryngology Head and Neck Surgery Society of Chinese Medical Association, Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery. Guideline of diagnosis and treatment of sudden deafness(2005, Jinan)[J]. Chin J Otorhinolaryngol Head Neck Surg, 2006, 41(8): 569. doi:10.3760/j.issn: 1673-0860.2006.08.003.
[2] Seggas I, Koltsidopoulos P, Bibas A, et al. Intratympanic steroid therapy for sudden hearing loss: a review of the literature[J]. Otol Neurotol, 2011, 32(1): 29-35. doi:10.1097/mao.0b013e3181f7aba3.
[3] Sennaro glu L, Dini FM, Sennaro glu G, et al. Transtympanic dexamethasone application in Ménière's disease: an alternative treatment for intractable Vertigo[J]. J Laryngol Otol, 1999, 113(3): 217-221. doi:10.1017/s0022215100143610.
[4] HIGGINS JPT, GREEN S(editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March2011]. The Cochrane Collaboration, 2011. Available from www.co-chrane-handbook.org.
[5] 陈声伟, 陈伟东, 林楚标, 等. 地塞米松不同途径给药治疗突发性聋的临床效果比较[J]. 中国当代医药, 2019, 26(26): 123-126. doi: 10.3969/j.issn.1674-4721.2019.26.037. CHEN Shengwei, CHEN Weidong, LIN Chubiao, et al. Clinical effect comparison of Dexamethasone on sudden deafness treated by different administration routes[J]. China Mod Med, 2019, 26(26): 123-126. doi: 10.3969/j.issn.1674-4721.2019.26.037.
[6] 付丽艳, 刘卓慧, 龙瑞清. 鼓室内与静脉注射地塞米松治疗突发性聋疗效比较[J]. 听力学及言语疾病杂志, 2018, 26(4): 350-353. doi: 10.3969/j.issn.1006-7299.2018.04.004. FU Liyan, LIU Zhuohui, LONG Ruiqing. Efficacy analysis of intratympanic and intravenous dexamethasone in idiopathic sudden sensorineural hearing loss[J]. J Audiol Speech Pathol, 2018, 26(4): 350-353. doi: 10.3969/j.issn.1006-7299.2018.04.004.
[7] 李晖, 刘莉, 郭筠芳. 鼓室注射地塞米松治疗突发性聋的疗效及影响因素分析[J]. 听力学及言语疾病杂志, 2013,21(5): 539-541. doi: 10.3969/j.issn.1006-7299.2013.05.028.
[8] Seok Ming Hong. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSNL[J]. Otolaryngology-Head and Neck Surgery, 2009, 141:579-583.
[9] Lim HJ, Kim YT, Choi SJ, et al. Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss[J]. Otolaryngol Head Neck Surg, 2013, 148(1): 121-127. doi:10.1177/0194599812464475.
[10] Tsounis M, Psillas G, Tsalighopoulos M, et al. Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial[J]. Eur Arch Otorhinolaryngol, 2018, 275(1): 103-110. doi:10.1007/s00405-017-4803-5.
[11] Tong B, Wang Q, Dai Q, et al. Efficacy of various corticosteroid treatment modalities for the initial treatment of idiopathic sudden hearing loss: a prospective randomized controlled trial[J]. Audiol Neurootol, 2021, 26(1): 45-52. doi:10.1159/000508124.
[12] Rauch SD, Halpin CF, Antonelli PJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial[J]. JAMA, 2011, 305(20): 2071-2079. doi:10.1001/jama.2011.679.
[13] Swachia K, Sharma D, Singh J. Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss[J]. J Basic Clin Physiol Pharmacol, 2016, 27(4): 371-377. doi:10.1515/jbcpp-2015-0112.
[14] Rajati M, Azarpajooh MR, Mouhebati M, et al. Is sudden hearing loss associated with atherosclerosis?[J]. Iran J Otorhinolaryngol, 2016, 28(86): 189-195. PMID: 27429947.
[15] Mohammed AAM. Lipid profile among patients with sudden sensorineural hearing loss[J]. Indian J Otolaryngol Head Neck Surg, 2014, 66(4): 425-428. doi:10.1007/s12070-014-0744-0.
[16] 施典羽, 杨凯, 敬光怀, 等. 特发性突聋患者外周血ET、CGRP和NO的检测分析[J]. 中国中西医结合耳鼻咽喉科杂志, 2012, 20(4): 246-248, 245. doi: CNKI:SUN:XYJH.0.2012-04-004. SHI Dianyu, YANG Kai, JING Guanghuai, et al. The Detection and analysis of ET, CGRP, NO in the ISSHL Patients' peripheral blood[J]. 2012, 20(4): 246-248, 245. doi: CNKI:SUN:XYJH.0.2012-04-004.
[17] 赵鹏举, 刘阳, 王庆军, 等. 突发性耳聋患者内淋巴积水的客观影像检测[J]. 中华耳科学杂志, 2016,14(6): 764-768. doi: 10.3969/j.issn.1672-2922.2016.06.013. ZHAO Pengju, LIU Yang, WANG Qingjun, et al. MRI detction of endolymphatic Hydrops in patients with sudden sensorineural hearing loss[J]. Chin J Otol, 2016, 14(6): 764-768. doi: 10.3969/j.issn.1672-2922.2016.06.013.
[18] 李和清, 任基浩, 卢永德. 突聋血清病毒特异性IgM抗体及NO检测的初步研究[J]. 中国耳鼻咽喉颅底外科杂志, 2002, 6(2): 133-134. doi: 10.3969/j.issn.1007-1520.2002.02.023.
[19] 刘瑶, 管国芳, 孙开, 等. 突发性耳聋与巨细胞病毒感染关系初探[J]. 吉林医学, 2011,32(13): 2513-2514. doi: 10.3969/j.issn.1004-0412.2011.13.006. LIU Yao, GUAN Guofang, SUN Kai, et al. Preliminary research on relationship between sudden deafness and Cytomegalovirus infection[J]. Jilin Med J, 2011, 32(13): 2513-2514. doi: 10.3969/j.issn.1004-0412.2011.13.006.
[20] 原晶晶,鲍诗平,张帆,等.慢性乙型肝炎病毒感染与听力相关性初步研究[J]. 中国听力语言康复科学杂志,2016, 14(6):428-431. doi:10.3969/j.issn.1672-4933.2016.06.008. YUN Jingjing, BAO Shiping, ZHANG Fan, et al. A preliminary study on the correction between chronic hepatitis B virus infection and hearing status [J]. Chinese Scientific Journal of Hearing and Speech Rehabilitation, 2016, 14(6):428-431. doi:10.3969/j.issn.1672-4933.2016.06.008.
[21] Rossini BAA, Penido NO, Munhoz MSL, et al. Sudden sensorioneural hearing loss and autoimmune systemic diseases[J]. Int Arch Otorhinolaryngol, 2017, 21(3): 213-223. doi:10.1055/s-0036-1586162.
[22] 衡伟伟, 后婕, 魏先梅, 等. TNF-α和IL-8在突发性聋患者血清及外周血单个核细胞中的表达及其意义[J]. 山东大学耳鼻喉眼学报, 2016,30(2): 40-45. doi: 10.6040/j.issn.1673-3770.0.2015.473. HENG Weiwei, HOU Jie, WEI Xianmei, et al. Expressions and significance of TNF-α and IL-8 in serum and peripheral blood mononuclear cells from patients with sudden sensorineural hearing loss[J]. J Otolaryngol Ophthalmol Shandong Univ, 2016, 30(2): 40-45. doi: 10.6040/j.issn.1673-3770.0.2015.473.
[23] 梁敏, 吴悔, 陈建勇, 等. 前庭诱发肌源性电位预测突聋患者疗效的临床价值[J]. 山东大学耳鼻喉眼学报, 2020,34(5): 27-32. doi: 10.6040/j.issn.1673-3770.1.2020.063. LIANG Min, WU Hui, CHEN Jianyong, et al. Clinical value of vestibular evoked myogenic potential to predict prognosis of unilateral idiopathic sudden sensorineural hearing loss[J]. J Otolaryngol Ophthalmol Shandong Univ, 2020, 34(5): 27-32. doi: 10.6040/j.issn.1673-3770.1.2020.063.
[24] Silverstein H, Thompson J, Rosenberg SI, et al. Silverstein MicroWick[J]. Otolaryngol Clin N Am, 2004, 37(5): 1019-1034. doi:10.1016/j.otc.2004.04.002.
[25] 孙爱华, LorneS.Parnes, DavidJ. Freeman, 等. 不同用药途径地塞米松在内耳液中的分布[J]. 中华耳鼻咽喉科杂志, 2001, 36(1): 62-63. doi: 10.3760/j.issn:1673-0860.2001.01.021.
[26] Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application[J]. Laryngoscope, 1999, 109(7 pt 2): 1-17. doi:10.1097/00005537-199907001-00001.
[27] 李穗, 龚树生, 陈建国, 等. 3种糖皮质激素经圆窗膜给药在内耳的药代动力学研究[J]. 临床耳鼻咽喉科杂志, 2005, 19(1): 24-26. doi: 10.3969/j.issn.1001-1781.2005.01.010. LI Sui, GONG Shusheng, CHEN Jianguo, et al. Pharmacokinetics of the methylprednisolone,dexamethasone and hydrocortisone in the inner ear after administered via round window[J]. Journal of Clinical Otorhinolaryngology, 2005, 19(1): 24-26. doi: 10.3969/j.issn.1001-1781.2005.01.010.
[28] Plontke SK, Biegner T, Kammerer B, et al. Dexamethasone concentration gradients along Scala tympani after application to the round window membrane[J]. Otol Neurotol, 2008, 29: 401-406. doi: 10.1097/MAO.0b013e318161aaae.
[29] 严小玲, 毛敏, 翟锦明, 等. 鼓室内注射治疗难治性突发性耳聋52例[J]. 山东大学耳鼻喉眼学报, 2014, 28(5): 23-26. doi: 10.6040/j.issn.1673-3770.0.2014.045. YAN Xiaoling, MAO Min, ZHAI Jinming, et al. Intratympanic steroids to treat refractory sudden sensorineural hearing loss(52 cases report)[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2014, 28(5): 23-26. doi: 10.6040/j.issn.1673-3770.0.2014.045.
[30] Marx M, Younes E, Chandrasekhar SS, et al. International consensus(ICON)on treatment of sudden sensorineural hearing loss[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2018, 135(1s): S23-S28. doi:10.1016/j.anorl.2017.12.011.
[1] FANG Lu, LEI Yudan, WANG Hua. Meta-analysis of clinical effect of cyclosporine eye drops in combination with sodium hyaluronate eye drops in the treatment of dry eye syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 65-73.
[2] LEI Yudan, FANG Lu, CHEN Jian, PENG Changfu. Meta-analysis of clinical Efficacy of tocilizumab in the treatment of moderate-to-severe thyroid-associated ophthalmopathy with steroid resistance or intolerance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 54-67.
[3] SUN Qingzhu, SHEN Jian, CHEN Xing, WU Yanbing, ZENG Lun. The role of metabolic indicators in predicting ranibizumab efficacy in diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 74-81.
[4] XU Xuemeng, FAN Lei, YU Wangbo, JIANG Zhiyue, PAN Chen, HUANG Yongqin. Meta-analysis of the efficacy of omalizumab in combination with specific immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 26-33.
[5] LIU Yijun, GU Yue, GUAN Dayu, YANG Yucheng, SHEN Yang. The long-term clinical efficacy and safety of vidian neurectomy in refractory allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 42-48.
[6] SUN Chunxiao, WANG Wenqing, YUE Tian, LIU Jisheng. Efficacy analysis of concurrent chemoradiotherapy with high and low cumulative cisplatin doses in the treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 31-41.
[7] ZHENG Zehao, WEI Jiali, LIU Jiatao, ZHOU Yuqi, SUN Wenting, LI Yuxuan, BAI Peng. Evaluation of the efficacy and safety of site-specific acupuncture for the treatment of sudden hearing loss: a systematic review and network Meta-analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 114-127.
[8] ZOU Song, XU Baoyuan, ZHANG Jinxing, CHEN Qiaoting, LI Jianxiang. The effect of ABCLOVE voice training method on voice function in patients undergoing surgery for benign proliferative lesions of the vocal cords [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 32-37.
[9] CAO Zhengyong, LI Xiaobo. Comparison of the safety and efficacy of short-course postoperative topical glucocorticoid adjuvant therapy for eCRSwNP combined with asthma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 43-50.
[10] CHEN Danping, HE Zijian, YU Youjun, ZHOU Xiaowei. Analysis of the efficacy and prognostic factors of hospitalized cases of children with sudden sensorineural hearing loss for ten years [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 16-22.
[11] MI Xueqin, LI Songzhe, DENG Yingjie, LI Shengyang, XIAO Dingqi, FAN Lei. Meta-analysis of the clinical efficacy and safety of proton pump inhibitors versus gastric mucosal protective agents in the treatment of laryngopharyngeal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 136-142.
[12] WANG Zhenxiao, SHI Guanggang, HE Mingqiang, SHI Lei. Treatment options and management strategies for patients with acute laryngotracheobronchitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 136-144.
[13] WANG Kaijian, CHEN Xuesheng, WANG Wei. A meta-analysis of the correlation between platelet-lymphocyte ratio and prognosis of laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 67-73.
[14] LI Yang, LIU Dong, CAO Wenjie. Meta-analysis of the effect of red-light therapy on spherical equivalent, axial length, and choroidal thickness in myopic children [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 74-81.
[15] LI Shuting, ZHAO Hui, SI Mingwei, CUI Wenxuan, YANG Mengyao, WANG Hong. Fungal endophthalmitis in a patient with no history of vegetative trauma: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 103-108.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd